Additional file 1 of Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Autor: Pageaux, Georges-Philippe, Nzinga, Clovis Lusivika, Ganne, Nathalie, Samuel, Didier, Dorival, C��line, Zoulim, Fabien, Cagnot, Carole, Decaens, Thomas, Thabut, Dominique, Asselah, Tarik, Mathurin, Philippe, Habersetzer, Fran��ois, Bronowicki, Jean-Pierre, Guyader, Dominique, Rosa, Isabelle, Leroy, Vincent, Chazouilleres, Olivier, de Ledinghen, Victor, Bourliere, Marc, Causse, Xavier, Cales, Paul, Metivier, Sophie, Loustaud-Ratti, V��ronique, Riachi, Ghassan, Alric, Laurent, Gelu-Simeon, Moana, Minello, Anne, Gournay, J��r��me, Geist, Claire, Tran, Albert, Abergel, Armand, Portal, Isabelle, d���Alteroche, Louis, Raffi, Fran��ois, Fontaine, H��l��ne, Carrat, Fabrice, Pol, Stanislas
Rok vydání: 2022
DOI: 10.6084/m9.figshare.19084110.v1
Popis: Additional file 1: Table S1. Balance of baseline covariates following IPTW analysis according to DAA exposure. Table S2. Summary of non-liver related deaths by cause. Table S3. Summary of liver related deaths by cause. Table S4. Factors associated with HCC, all-cause mortality, and liver transplant in all 559 patients included for study. Table S5. Characteristics of hepatocellular carcinoma according to DAA exposure. Table S6. Incidence rates of hepatocellular carcinoma, all-cause mortality, liver-related mortality, non-liver-related mortality, and liver transplant in all 559 patients under study according to DAA exposure period and virological response status. Table S7. Incidence rates of hepatocellular carcinoma, all-cause mortality, liver-related mortality, non-liver-related mortality, and liver transplant in all 55 patients with a Meld score>20 or Child-Pugh score C according to DAA exposure period and virological response status.
Databáze: OpenAIRE